Abstract:Background: Baicalin (BCL), a candidate drug for ischemic stroke, has been indicated to protect neurons by promoting brain-derived neurotrophic factor (BDNF). However, the cellular source of BDNF release promoted by baicalin and its detailed protective mechanism after ischemia/reperfusion remains to be studied. The aim of this study was to investigate the neuroprotective mechanisms of baicalin against oxygen–glucose deprivation/reoxygenation (OGD/R) in a neuron–astrocyte coculture system and to explore whether the BDNF-TrkB pathway is involved.Methods and Results: A neuron–astrocyte coculture system was established to elucidate the role of astrocytes in neurons under OGD/R conditions. The results demonstrated that astrocytes became reactive astrocytes and released more BDNF in the coculture system to attenuate neuronal apoptosis and injury after OGD/R. BCL maintained the characteristics of reactive astrocytes and obviously increased the expression of cyclic AMP response element-binding protein (CREB) and the levels of BDNF in the coculture system after OGD/R. To further verify whether BDNF binding to its receptor tyrosine kinase receptor B (TrkB) was required for the neuroprotective effect of baicalin, we examined the effect of ANA-12, an antagonist of TrkB, on NA system injury, including oxidative stress, inflammation, and apoptosis induced by OGD/R. The results showed that treatment of NA systems with ANA-12 significantly attenuated the neuroprotection of BCL. The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) and mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathways are two important downstream cascades of signaling pathways activated by BDNF binding to TrkB. We investigated the expressions of TrkB, PI3K, Akt, MAPK, and ERK. The results demonstrated that baicalin significantly increased the expressions of TrkB, PI3K/AKT, and MAPK/ERK.Conclusion: The neuroprotective effects of baicalin against oxidative stress, inflammation, and apoptosis were improved by astrocytes, mainly mediated by increasing the release of BDNF and its associated receptor TrkB and downstream signaling regulators PI3K/Akt and MAPK/ERK1/2.

Baicalin Attenuates Oxygen–Glucose Deprivation/Reoxygenation–Induced Injury by Modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 Signaling Axes in Neuron–Astrocyte Cocultures

Baicalin alleviates oxygen–glucose deprivation/reoxygenation‐induced SK‐N‐SH cell injury via the regulation of miR‐556‐3p/ACSL4 pathway

Baicalin Attenuates Neuronal Damage Associated with SDH Activation and PDK2-PDH Axis Dysfunction in Early Reperfusion

Baicalin combats glutamate excitotoxicity via protecting glutamine synthetase from ROS-induced 20S proteasomal degradation

Baicalin attenuates in vivo and in vitro hyperglycemia-exacerbated ischemia/reperfusion injury by regulating mitochondrial function in a manner dependent on AMPK.

Effect of Baicalin on Oxygen-Glucose Deprivation/Reperfusion-Induced Injury in Mouse Brain Slices and Cultured Rat Cortical Neurons

Protective Effects of Baicalin on Oxygen/Glucose Deprivation- and Nmda-Induced Injuries in Rat Hippocampal Slices

Baicalin Can Scavenge Peroxynitrite and Ameliorate Endogenous Peroxynitrite-Mediated Neurotoxicity in Cerebral Ischemia-Reperfusion Injury

Pretreatment with baicalin attenuates hypoxia and glucose deprivation-induced injury in SH-SY5Y cells

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway.

Comprehensive Study of Baicalin Down-Regulating Nod2 Receptor Expression of Neurons with Oxygen-Glucose Deprivation in Vitro and Cerebral Ischemia-Reperfusion in Vivo

Effects of Baicalin on Neuronal Apoptosis and Related Gene Expression after Focal Cerebral Ischemia-Reperfusion Injury in Rats

Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons.

Role of Baicalin in Regulating Toll-like Receptor 2/4 after Ischemic Neuronal Injury.

Baicalin Attenuates Proinflammatory Cytokine Production In Oxygen-Glucose Deprived Challenged Rat Microglial Cells By Inhibiting Tlr4 Signaling Pathway

Protective effect of baicalin on focal cerebral ischemia-reperfusion injury in rats

Baicalin Protects Neonatal Rat Brains Against Hypoxic-Ischemic Injury by Upregulating Glutamate Transporter 1 Via the Phosphoinositide 3-Kinase/protein Kinase B Signaling Pathway

Identification of potential regulating effect of baicalin on NFκB/CCL2/CCR2 signaling pathway in rats with cerebral ischemia by antibody-based array and bioinformatics analysis

Baicalin Attenuates Focal Cerebral Ischemic Reperfusion Injury by Inhibition of Protease-Activated Receptor-1 and Apoptosis.

The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model

Baicalin Administration is Effective in Positive Regulation of Twenty-Four Ischemia/reperfusion-Related Proteins Identified by a Proteomic Study